CRSP vs. NEE
CRSP (CRISPR Therapeutics AG) and NEE (NextEra Energy, Inc.) are both stocks. CRSP operates in Biotechnology (Healthcare), while NEE operates in Utilities - Regulated Electric (Utilities). Over the past 5 years, CRSP returned -17.08%/yr vs 5.94%/yr for NEE. At a 0.13 correlation, their price movements are largely independent.
Performance
CRSP vs. NEE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CRSP achieves a -5.03% return, which is significantly lower than NEE's 8.63% return.
CRSP
- 1D
- -0.86%
- 1M
- 2.87%
- YTD
- -5.03%
- 6M
- -12.14%
- 1Y
- 20.41%
- 3Y*
- -6.43%
- 5Y*
- -17.08%
- 10Y*
- —
NEE
- 1D
- 1.36%
- 1M
- -7.22%
- YTD
- 8.63%
- 6M
- 6.81%
- 1Y
- 18.32%
- 3Y*
- 8.11%
- 5Y*
- 5.94%
- 10Y*
- 13.51%
CRSP vs. NEE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CRSP CRISPR Therapeutics AG | -5.03% | 33.23% | -37.12% | 54.00% | -46.36% | -50.51% | 151.39% | 113.18% | 21.68% | 15.89% |
NEE NextEra Energy, Inc. | 8.63% | 15.47% | 21.46% | -25.30% | -8.54% | 23.39% | 30.06% | 42.69% | 14.30% | 34.39% |
Correlation
The correlation between CRSP and NEE is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.06 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.13 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.17 |
Correlation (All Time) Calculated using the full available price history since Oct 19, 2016 | 0.13 |
The correlation between CRSP and NEE shifts across timeframes, from 0.06 (1 year) to 0.17 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
CRSP:
-$6.24
NEE:
$5.27
CRSP:
1.11K
NEE:
4.78
CRSP:
$4.10M
NEE:
$27.93B
CRSP:
-$171.17M
NEE:
$13.35B
CRSP:
-$509.21M
NEE:
$14.56B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRSP vs. NEE — Risk / Return Rank
CRSP
NEE
CRSP vs. NEE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for CRISPR Therapeutics AG (CRSP) and NextEra Energy, Inc. (NEE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CRSP | NEE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.51 | ||
| Sortino ratioReturn per unit of downside risk | -0.35 | ||
| Omega ratioGain probability vs. loss probability | 1.11 | 1.17 | -0.06 |
| Calmar ratioReturn relative to maximum drawdown | 0.49 | 1.37 | -0.88 |
| Martin ratioReturn relative to average drawdown | 0.81 | 3.78 | -2.97 |
Loading charts...
Drawdowns
CRSP vs. NEE - Drawdown Comparison
The maximum CRSP drawdown since its inception was -85.11%, which is greater than NEE's maximum drawdown of -47.81%. Use the drawdown chart below to compare losses from any high point for CRSP and NEE.
Loading charts...
Drawdown Indicators
| CRSP | NEE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -85.11% | -47.81% | -37.30% |
Max Drawdown (1Y)Largest decline over 1 year | -42.25% | -14.53% | -27.72% |
Max Drawdown (3Y)Largest decline over 3 years | -64.91% | -34.57% | -30.34% |
Max Drawdown (5Y)Largest decline over 5 years | -80.68% | -44.97% | -35.71% |
Max Drawdown (10Y)Largest decline over 10 years | — | -44.97% | — |
Current DrawdownCurrent decline from peak | -76.29% | -11.50% | -64.79% |
Average DrawdownAverage peak-to-trough decline | -49.24% | -8.93% | -40.31% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 25.51% | 5.25% | +20.26% |
Volatility
CRSP vs. NEE - Volatility Comparison
CRISPR Therapeutics AG (CRSP) has a higher volatility of 18.22% compared to NextEra Energy, Inc. (NEE) at 8.52%. This indicates that CRSP's price experiences larger fluctuations and is considered to be riskier than NEE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CRSP | NEE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 18.22% | 8.52% | +9.70% |
Volatility (6M)Calculated over the trailing 6-month period | 43.62% | 16.75% | +26.87% |
Volatility (1Y)Calculated over the trailing 1-year period | 62.44% | 23.78% | +38.66% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 60.65% | 26.91% | +33.74% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 64.35% | 25.49% | +38.86% |
Dividends
CRSP vs. NEE - Dividend Comparison
CRSP has not paid dividends to shareholders, while NEE's dividend yield for the trailing twelve months is around 2.77%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CRSP CRISPR Therapeutics AG | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NEE NextEra Energy, Inc. | 2.77% | 2.82% | 2.87% | 3.08% | 2.03% | 1.65% | 1.81% | 2.06% | 2.55% | 2.52% | 2.91% | 2.96% |
Financials
CRSP vs. NEE - Financials Comparison
This section allows you to compare key financial metrics between CRISPR Therapeutics AG and NextEra Energy, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CRSP and NEE have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CRSP has higher volatility (18.22%) compared to NEE (8.52%). In terms of maximum drawdown, CRSP dropped -85.11% vs NEE's -47.81%.
NEE currently has the higher Sharpe Ratio (0.84 vs 0.33), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CRSP and NEE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer